Clinical Trials Logo

Filter by:
NCT ID: NCT03588468 Completed - Clinical trials for Transthyretin Amyloidosis

Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study

Start date: September 20, 2018
Phase: N/A
Study type: Interventional

Familial amyloid neuropathies (FAP) are hereditary disease due to a mutation of the tranthyretin gene (TTR). These neuropathies are severe and life frightening. Asymptomatic carrier of TTR mutation are now detected in large TTR-FAP family. However, it is very hard to detect the moment where a TTR mutation carrier become symptomatic: too early diagnosis exposes the patients to side effect of the treatment and too late diagnosis exposes the patient to disease progression and clinical sequels. Neurological monitoring comprises clinical examination, electrophysiology and imaging. Sensitivity and specificity of these tools are not sufficient and we have to develop new biomarkers sensitive enough to detect modifications under treatment and the moment where a TTR mutation carrier become symptomatic Magnetic resonance imaging (MRI) can well evaluate neuromuscular diseases. Electrophysiological examination is also a good tool to evaluate NAF. MUNIX is a technique that permits to estimate the number of motor unit in one muscl. MUNIX is related to the disability in chronic inflammatory neuropathies and could be more sensitive than clinical scales and other electrophysiological data to detect modification of the disease in TTR-FAP. The objective of this exploratory study is to test the applicability of MUNIX and MRI as early measures for detecting the transition from asymptomatic to symptomatic TTR-FAP. In symptomatic TTR-FAP we will determine if MUNIX and MRI data are related to clinical deficiency and disability of the patients. This is a transversal exploratory study. If we manage to demonstrate that MRI and MUNIX can segregate symptomatic versus asymptomatic TTR mutation gene carriers, we will propose a longitudinal study with a follow up of more asymptomatic gene carriers.

NCT ID: NCT03588455 Completed - Coronary Stenosis Clinical Trials

Pronostic Impact of Flow Fraction Reserve on Intermediate Stenoses

Start date: January 1, 2018
Phase:
Study type: Observational

The intermediate coronary stenoses defined by a degree of stenosis from 40 to 70 % are frequent. The Flow Fraction Reserve (FFR), realized during coronarography, is an hemodynamic evaluation by the functional impact measuring the loss of load in upstream / approval of the stenosis inthe basal state and in situation of hyperemia led by adenosine. Further to the study FAME, the threshold of definition of the significant character of one Stenosis was fixed for a value of FFR = 0,80. However, the impact forecasts intermediate values badly known rest. We hypothetized that coronary stenosis associated with borderline values of FFR 0.81-0.85 were associated with a higher rate of clinical events than those with a FFR >0.85

NCT ID: NCT03588325 Completed - Sepsis Clinical Trials

Evaluation of MDW for Early Detection of Sepsis, Clinical Validity

Start date: August 8, 2018
Phase:
Study type: Observational

The purpose of this study is to confirm the clinical validity and the performance of the Monocyte Width Distribution (MDW) parameter to detect the development of sepsis in a prospective study of Emergency Department (ED) adults who have blood draw including Complete Blood Count with differential (CBC-DIFF) ordered upon presentation in a Spanish & French hospital and to verify cut-off for Tri-potassium ethylenediaminetetraacetic acid (K3EDTA).

NCT ID: NCT03588169 Completed - Malnutrition Clinical Trials

Representations of Oral Nutritional Supplementation (ONS) in Hospitals : Gender differences_observational Study

CNO_ALIMS
Start date: January 14, 2019
Phase:
Study type: Observational

Over 30% of hospitalized patients are malnourished. These figures range from 20% to 60% in geriatric units. Undernutrition results either from a decrease in energy intake, an increase in needs, an increase in losses or a combination of these three causes. As a factor in mortality, morbidity and lengthening the time of hospital stays, undernutrition induces health costs 45 to 102% higher than a person who is not undernourished. The nutritional management of patients initially includes hygieno-dietary advice, then the implementation of an oral nutritional supplementation (ONS). A recent study conducted by our teams highlighted the low ONS consumption among women compared to men (39.48% vs 73.41%). Interviews with patients showed that 13 out of 17 had a negative opinion of ONS. The aim of this study is to show, on a larger scale, whether ONS consumption differs according to sex and if so, to highlight the obstacles to this consumption through the implementation of semi-directive interviews with patients. Ultimately, this research will lead to the implementation of alternative strategies to improve ONS consumption and to a better understanding of the obstacles to ONS consumption.

NCT ID: NCT03587792 Completed - Clinical trials for Unilateral Hearing Loss

Study of Binaural Squelch Effect in Unilateral Otosclerosis

CBOU
Start date: March 6, 2018
Phase:
Study type: Observational [Patient Registry]

Patients with unilateral transmission hypoacusis due to otosclerosis undergoing stapedectomy surgery will be prospectively included. They will be undergoing a free field vocal audiometry using the Oldenburg MATRIX software to evaluated the squelch effect gain between audiometry before and after 9months after surgery. Our hypothesis is to show a squelch effect with the rehabilitation of the binaural audition.

NCT ID: NCT03587376 Completed - Alzheimer Disease Clinical Trials

Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat)

Start date: May 30, 2018
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to determine T-cell mediated inflammatory immune response in some participants previously exposed to atabecestat.

NCT ID: NCT03587090 Completed - Clinical trials for Inferior Vena Cava Diameter

Comparison of Subcostal and Transhepatic Views to Assess Inferior Vena Cava by Echocardiography

VCI ECHO
Start date: May 14, 2018
Phase:
Study type: Observational

Comparison of subcostal and transhepatic views to measure inferior vena cava diameter by echocardiography in intensive care unit patients

NCT ID: NCT03586765 Completed - Overweight Clinical Trials

Epidemiology of Urinary Functional Disorders in Women of 40 and More

Start date: November 13, 2017
Phase:
Study type: Observational

Assess prevalence of urinary functional disorders in women of 40 and more, visiting a general practitioner, occupational medicine or health examination center in Puy-de-Dôme. Study conducted for a month using a self-filled survey distributed by secretaries or nurses.

NCT ID: NCT03586635 Completed - Clinical trials for MS CHRONIC PROGRESSIVE

Automated EDSS Score Calculation by Smartphone Application

Easy EDSS
Start date: December 13, 2018
Phase:
Study type: Observational

The EDSS score is the reference tool for rating disability in patients with multiple sclerosis. It is used in both daily monitoring and clinical research studies. Its main shortcoming lies in its imprecise and variable nature, with significant inter-examiner variability. This variability is the consequence of the complexity of the score rating and also of its subjective nature. The application developed aims to reduce the risk of rating error, and to homogenize the results obtained regardless of the examiner and his experience in using the score.

NCT ID: NCT03586505 Completed - Keratitis Clinical Trials

Tolerance to Light for Patients Suffering From Keratitis

EBLOUI
Start date: July 3, 2018
Phase: N/A
Study type: Interventional

In order to develop an innovative device to study infectious keratitis, we need to illuminate the cornea of patients suffering from an infectious keratitis with red or near-infrared light. Because of technical reasons the shortest possible wavelength (red) presents advantages.